Professionals and executives from the pharma, medical device, biotech, and life science medical fields, are invited to attend the premiere Clinical Research in Latin America Summit by DGE, streaming online on February 9-10th, 2023. Latin America is a crucial growth zone for the future of clinical research and has numerous ethnic groups, meaning greater representation of diverse groups in clinical trials. The challenges lie in areas like logistics, resources, and publications. Get all your questions answered and gain valuable guidance from a diverse community of experts at the Clinical Research in Latin America Summit by DGE.
The event is organized by Dynamic Global Events (“DGE”), a leading life science B2B event organizing company. DGE events is devoted to offering a viable forum for discussion and interaction with the medical industry. Timely and important topics are discussed by experts on DGE’s platforms, with an immersive audience, and live-streamed on. The events are attended by specialists of global acclaim with profound experience and knowledge in their respective fields.
At the Clinical Research In Latin America Summit, industry leaders and experts will offer their valuable advice on successfully employing strategies to conduct clinical research and execute viable clinical trials throughout the region. In the evolving landscape, it is critical to consider demographics covering diverse areas like Latin America in clinical trials—keeping these population-concentrated areas in mind, it is important to design futuristic strategies in clinical trials. Industry-leading experts will discuss ways to overcome hurdles to achieve greater patient retention and enrollment in Latin America.
Important issues to be discussed at the event:
- Clarifying the status of the current landscape and that of the highly skilled HCPs
- Understanding how to explore the different multiple regulatory frameworks
- Better engagement across different sectors of regional cross-collaborations
- Embracing robust medical strategies to reduce the gaps in patient knowledge
- Ways to perform the task of eradicating hurdles of local research capacity
- Learning novel ideas to make up for the low volume of publications
Join leading experts in the biopharma sector as they unveil actionable strategies for study coordination, site interaction, patient enrollment, partnership design, regulatory compliance, and much more. This DGE event aims to build a robust research pipeline through improved collaboration strategies, renewed public outreach, and a commitment to diversity.
To learn more, please visit https://nnw.fm/ZS6Hr
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 50+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
No comments:
Post a Comment